



































































































































































































protein L8 mRNA (U67771)， and changes in concentration were calculated. Gel 
electrophoresis and melting curve analyses were performed to confirm correct副nplicon
size and the absence of nonspecific bands. Quantification of mRNAs was repeated three 
times with independent mice， and average levels of change were calculated. Statistical 
analysis in Q手CRwas conducted by ANOVA test. 
Results 
DNA Microarray Analysis 
We examined gene expression in the oviduct， uterus and vagina at GD 19 in 
DES-exposed mice and oil controls. The correlation coefficients of microarray chips 
were average 0.980 (minimum: 0.967， maximum: 0.996). Genes showing at least 2-fold 
expression change in DES-exposed mice were 1isted in 
http://www.nibb.ac.jplbioenvl/suzuki/suzukidata004.html. 
To examine the gene expression changes by DES in由ethree organs ofthe 
Mullerian duct origin， we analyzed clustering pa悦 mofDES-regulated genes. 
Clustering analysis in controls revealed that organ specificity of gene expression. 
Genes in the uterus were c10se to the oviduct than the vagina. However， clustering 
13 
analysis in DES-exposed mice revealed that DES耐regulatedgenes in the three organs 
show less organ specificity as compared to controls (Fig. 1). 
DES up-regulated 387，387 and 225 genes， and down“regulated 177，172 and 75 
genes in the oviduct， uterus and vagina， respectively (Fig. 2). 72 up-regulated genes and 
15 down-regulated genes were commonly found in the three organs. In the oviduct， 
DESup帽regulatedand dOWIトregulatedgenes were 233如 d105， respectively. In the 
uterus， DES up-regulated and down-regulated genes were175 and 86， respectively. 
While， the vagina showed 77 DES up-regulated and 26 down-regulated genes (Fig. 2). 
We focused on genes related to signal transduction and organogenesis in 
DES-exposed Mul1erian duct (Table 2). Expressions ofRAB 20 and E74-like factor 3 
were up-regulated in al DES-exposed organs. While， expressions of prostaglandin E 
receptor 3， tumor necrosis factor receptor superfamily member 19， Eph receptor A7 and 
naked cuticle 2 (Nkd2) were down-regulated in al1 DES-exposed organs (Table 2). 
Several organ-specific genes in DES-exposed mice were xpressed (Table 2). 
F orkhead box J 1 (foxj 1)， expressed in ciliated cells in the oviduct (41)， was one of 
oviduct-specific genes in DES幽exposedoviduct. While， insulin-like growth factor-I 
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Estrogens induce cell proliferation and differentiation whereas estrogen depletion results 
in atrophy accompanied by apoptosis in adult reproductive tracts such as the uterus and 
vagina (Evans et al.， 1990; Suzuk:i etα1.， 1996; Sato et α1.，2003). Estrogen exposure 
during a critical period in the early development induces persistent proliferation and 
keratinization in the vaginal epithelium (Takasugi et α1.， 1962; 1964). Diethylstilbestrol 
(DES)， a synthetic estrogen used to prevent miscarriage during the 1940's to the early 
1970's， induced vaginal clear cel carcinoma and uterine abnormalities in daughters of 
mothers exposed to DES during pregnancy (Herbst et al.， 1971). Similar abnormalities 
were reported in mice exposed to estrogens during a perinatal critical period (Takasugi et 
al.， 1962; 1964; Forsberg et al吋 1969).In female mice， various abnormalities， such as 
polyovular follicles， oviductal tumors， uterine epithelial metaplasia， persistent vaginal 
stratification and keratinization， vaginal adenosis and cervico-vaginal carcinomas， were 
induced by perinatal exposure to estrogens including DES (Takasugi et al.， 1962; 1964; 
Forsberg et al.， 1969; Dunn et al.， 1963; Newbold et α1.ラ1982;1985; Iguchi et al.， 1986; 
1992). 












































































































































































In oil treated controls， ratios ofBrdU-positive cells were not different among 
postnatal ages both in the epithelial cells and stromal cels. BrdU-posive cells in the 
vaginal epithelium were increased at PND 20 and PND 70 in the DES treated vaginae as 
compared to the oil controls. In contrast， BrdUエJ.幽-p幽
PND 0 and PND 5 (Fig. 5). 
Immunoreactions ofK1f4 and 14-3幽3sigma were observed in the vaginal epithelium and 
stroma at PND O. Klf4 staining appeむedrandomly in the nuc1ei of vaginal epithelial and 
stromal cels. 14-3・3sigma immunoreactivity was detected in the cytoplasm of vaginal 
epithelial cells th加 stromalcels. 14-3-3 
after the DES injection at PND 0 as compared to the controls. Strong staining of 14-3-3 
sigma and Klf4 was found in the vaginal epithelium of mice at PND70 with or without 
DES (data not shown). 
Discussion 
Estrogen， androgen and KGF exposure for 5 days from the day ofbirth induces 
persistent vaginal epithelial stratification in mice (Takasugi et al.， 1962; Forsberg et α1.ラ
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ぉble1. Sequences for primers used for a quantitative R T♂CR 
Genebank 
aceslOn 
No Name F orward primer Reverse primer 
む20344 Klf4 ACACAGGCGAGAAACCTTACCA AATTTCCACCCACAGCCGT 
14-3-3 
AF058798 slgma ACAAGGACAGCACCCTCATCA ACAGCGTCAGGTTGTCTCTCAG 
AJ005559 Sprr2a TCCTGTAGTGTGCTATGAGCAATG TTGCACAGGAGGGCATGTT 
AJ005564 Sprr2f TGAGGCTTCAGCAACAATGTCTT TTGGTGGTGGACACACAGGA 
AB003502 Gspt1 CAAGTATGCATTGCGCGTTTA CCCATCTGAGGGAAGTCCTTAA 
AI121305 EST TTATGTCCTCAGTCCGCAGCT TAGTGTTGCAGGTCTGTGGTCC 
AW048937 p21 TGAGACGCTTACAATCTGAGTGG AACATGTATTGTGGCTCCCTCC 
U00937 Gadd45α GAAGAAGGAAGCTGCGAGAAAA CCTGGCCATCCTAAATTAGCAGT 
Riもosomal
U67771 protein L8 ACAGAGCCGTTGTTGGTGTTG CAGCAGTTCCTCTTTGCCTTGT 
Spr， small proline-rich protein; Gspt1， Gl to S phase transcript 1; p21， cyclin-inhibitor 21; 
GADD45α， growth and DNA damage 45α; 
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Table 2. Induced or repressed genes in vagina 6 h after a single injection of DES剖only
PNDO 
Genebank No. FC Name 
AV170770 2.0 EST 
AI837116 2.4 solute carier family 41， member 1 
AI851565 2.5 RIKEN cDNA 1500034101 gene 
U58887 3.3 SH3・domainGRB2-1ike 3 
D50646 0.4 stromal cel derived factor 2 
AI425990 0.4 RI瓦ENcDNA C530046L02 gene 
AI646638 0.5 合equentlyrearranged in advanced T・celllymphomas2 
M12347 0.5 actin， alpha 1， skeletal muscle 
AI841689 0.5 chemokine-like factor super family 3 
62 
Table 3. Induced or repressed genes in vagina 6 h after a single injection ofDES at 
PND 0， 5， 20 and 70 using DNA microarray. 
Genebank Gene Age in days 
No. 。 5 20 70 
Induced genes 
Cell proliferation 
AB003502 G1 to phase transition 1 (Gspt1) 2.2 2.8 2.1 3.3 
V00727 c-fos 4.0 14.5 6.4 9.4 
U83902 MAD2 2.1 2.7 3.7 13.8 
X59846 Gas6 4.0 3.9 2.1 3.7 
AF058798 14-3・3sigma . 3.4 3.4 2.7 
AW048937 p21 - 2.4 3.2 3.7 
U00937 GADD45α .開 6.0 4.5 4.5 
Protein mod折Cation
AB013848 peptidyl arginine deiminase， 4.1 6.8 3.3 4.5 
type 1 
L02526 Map2k1 2.1 2.1 2.2 2.0 
X04591 creatine kinase， brain 2.1 2.5 2.1 4.3 
X59274 protein kinase C， beta 2.6 2.7 2.1 2.2 
Transcription 
M28845 early growth response 1 (Egr・1) 2.8 4.7 2.9 3.5 
U20344 Kruppel-like factor 4 (K]f4) 3.8 4.2 2.1 2.7 
Siglal cascade 
M63801 gap junction membrane channel 2.4 3.5 2.1 2.1 
p~otein alpha 1 
AI596360 RIKEN cDNA 4930422118 gene 3.1 7.2 2.6 2.8 
Unknown 
X67644 immediate early response 3 2.7 5.3 3.7 2.7 
AI121305 RIKEN cDNA 1600029D21 3.8 15.1 3.7 3.6 
g~ne 
Cell structure 
K02108 K 2， basic， gene 6a . 6.3 3.0 5.2 
AB012042 K 2， basic， gene 6g - 2.9 7.7 4.1 
札口6120 K 1， acidic， gene 19 " - - 2.6 
AJ005559 Sprr2a 幽 2.2 . 4.9 
AJ005560 Sprr2b 幽 開 構 4.4 
AJ005564 Sprr2f - 15.0 4.0 7.5 
ReQ戸ssedgenes 
Transport 
D16215 円前m叫 ning I 0.5 I 0.3 I 0.3 0.5 
monooxygenase 1 (Fmo 1) 
Gas 6， growth訂restspecific 6; Map2k1ラmitogenactivated protein kinase kinase 1; p21， 
cyclin-inhibitor 21; GADD45α， growth and DNA damage 45α; MAD2， mitotic arrest 




































































Fema1e reproductive organs vary their morphology during reproductive events， 
such as differentiation， development， estrous cyc1e， gestation and lactation. Estrogen is 
known to have differentia1 developmental effects widely on the uterus， vagina， 
mammary gland， bone， liver， thymus and brain as its target organs. Although the 
proliferation of uterine and vaginal epithelia， and ductal elongation of mammary gland 
in mice could be regulated by estrogen alone (Korach et al.， 1996)， the mamm訂ygland 
requires progesterone and prolactin in addition to estrogen to complete the architecture 
(Horseman et al.， 1999; Kelly et al.， 2002; Shay割問la，1999). Ovariectomy and 
termination of weaning induce apoptosis in epithelial cells in the uterus， vagina and 
mammary gland (Kojima et α1.， 1996; Sato et al.， 1996). These estrogen target organs 
are controlled by estrogen receptors (ERαand ERs) in the epithelial and stromal cells 
(Cunha et al.， 1997; Kurita et al.， 2000; Mueller et al.， 2002). It is known， moreove巳
that growth factor(s) from the stroma are involved in epithelial proliferation ofthese 
organs (Buchanan et al.， 1998; Cooke et al.， 1997; Cunha et al.， 1997). An increase of 
epithelial and stromal cells in the uterus and vagina is mediated through insulin-like 
growth factor 1 (IGF-l) and epidermal growth factor (EG匂(Buchananet al.， 1999; 
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Cooke et al.， 1997; Huet-Hudson et al.， 1990; Klotz et al.， 2002). Prolactin also induces 
expression ofIGF-2 mRNA in the developing mammary gland (Hovey et α1.，2003). 
Tamoxifen， a selective ER modulator (SERM)， acts as an estrogen agonist in the uterus 
and vagina， but acts as an estrogen antagonist in the mammary gland (Margeat et al.， 
2003; Shang et al.， 2002). The ligand-dependent effect on the mammary gland supports 
the idea of tissue specificity of gene expression by estrogen. Profiling of 
estrogen珊regulatedgene expression is reported recently in the estrogen target cells， 
tissues and organs (Frasor et al吋 2003;Watanabe et al.， 2002， 2003a and b). However， 
組 ycomparisons of gene expression in the estrogen target organs have not been reported. 
Gene expression reached a maximum 6 h after E2 administration in the uterus of 
ovariectomized adult mice without any histological changes (Watanabe et al.， 2002). 
Thus， we examined global gene expression 6 h after a single injection of E2 in order to 
identifシearlyestrogen-responsive genes in the uterus， vagina and mammary gland as 
the estrogen target organs in ovariectomized adult mice. 
Materals and Methods 
Animals 
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C57BLl6J mice (CLEA， Tokyo， Japan) at 2 months of age， 20-23 g body weight， were 
used for mating. Mice were maintained under 12 h lightl12 h dark at 23-25 oC， fed with 
a commercial diet (CE-2， CLEA) and provided tap water ad libitum. All experiments 
and animal husbandry protocols were approved by the animal care committee of 
National Institutes ofNatural Sciences. 
刀'eatmen釘
17s-Estradiol (E2， Sigma， S1.Louis， MO) was dissolved in sesame oil. Six句r-day-old
mice were ovariectomized and iniected with 5μg E2/kg body weight after a 10-day 
recovery period to ensure that endogenous E2 levels were reduced. Six h after E2 
injection， 4 mice were killed by decapitation and the uteri， vaginae and mammary 
glands were collected. Four mice injected with oil vehicle only were used as controls. 
The tissues were pooled for DNA microarray analysis and the analyses were done on 
two independent experiments. Two other groups of 4 ovariectomized mice were 




Total RNA was extracted合omtissues (4 mice each) 6 h after a single injection of 5μg 
E2/k:g b.w. or the oil vehic1e alone. Tep./-lg oftotal RNA were used to synthesize cDNA， 
which was then used to generate biotinylated cRNA.τhe cRNA was hybridized to 
murine U74A version 2 GeneChip expression arrays (A助metrix，Applied Biosystems 
(APB)， Tokyo， Japan) as described (Watanabe et al.， 2002). Total RNA was extracted 
using TRIzol reagent (Invitrogen， Tokyo， Japan) and purified with an RNeasy total RNA 
purification kit (Qiagen， Tokyo， Japan). Ten μg of total RNA were converted into 
double stranded cDNA using the Superscript Choice System (Invitrogen) with a 
T7・(dTh4primer (APB). Biotin-labeled cRNA was synthesized using the ENZO 
BioArray High Yield RNA transcript labeling kit (APB). The cRNA was purified by 
RNeasy (Qiagen). The purified cRNA was fragmented with 合agmentationbuffer ( 40 
mM Tris， 100 mM K・-acetateand 30 mM Mg-acetate) at 94 oC for 35 min. Fragmented 
cRNA was mixed with hybridization buffer containing 100 mM MES 
[2-(N-morpholino)ethanesulfonic acid]， 1 M NaCl， 20 mM EDTA， 0.01 % Tween 20 and 
control oligonuc1eotides. The司ualityof cRNA was first assessed by analysis with Test 2 
array (A的metrix).cRNA was hybridized to Murine U74A version 2 GeneChip 
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ExpressionArrays (Affymetrix) for 16 h at 450C. All preparations were performed 
following manufacturer's instructions. Arrays were washed and stained with 
streptavidin幽phycoerytherin，and scanned with an Argon-ion Laser Confocal Scanner 
(APB). Microarray組 alysiswas performed twice on independent samples [34] and 
these raw data were loaded into NCBIs Gene Expression Omnibus as the dataset 
GSM159919・GSM159930(GEO， http://www.ncbi.nlm.nih.立ov/geo1).τheputative 
target genes were validated by quantitative RT幽PCR(QR'下PCR).
Statistical analysis 
Signals in 2 experiments were detected using the robust multichip average (RMA) 
algorithms， and normalized using Genespring (Silicon GeneticsラRedwoodsCity， CA). 
Expressed genes more than 40% raw signal of average raw signals in al genes on chip 
were selected as detected genes for next analysis. Selected genes showing more than 
2-fold alterations by E2 as compared to the tissuかmatchedoil controls were analyzed 
長rrtherusing Genespring software. 
Quantitative RT-PCR 
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One μg total RNA was reverse transcribed using Super Script I reverse transcriptase 
(Invitrogen) and random primers at 42 oC for 50 min. PCR was performed using PE 
Prism 5700 Sequence Detection System (PE Biosystems， Tokyo， Japan) with SYBR 
Green 1 dye (Molecular Probes， Eugene， OR) and primers selected by Primer Express 
ver 1.0 (APB). Primer sets are described in Table 1. 
PCR amplification was performed for 2 min at 50 oC， for 10 min at 950C and continued 
to 40 cycles at 95 oC for 15 sec and at 60 oC for 1 min. Data were normalized to 
ribosomal protein 28S RNA using delta Ct method for each primer set. The ratio was 
calculated as compared with oil controls of uterus. 
BrdU-Labeling and Immunostaining 
A single injection of200 mg BrdU (Roche， Grenzacherstrasse， Switzerland)lkg b.w. was 
given to mice (4 mice each) 1 h before sacrifice. Uterus， vagina and m出nm訂ygland 
were fixed with neutral幽buffered10% formalin， embedded in para伍nand sectioned at 6 
μm. Sections were dipped in PBS and endogenous peroxidase activity was blocked with 
3% H202 in methanol for 30 min. After washing in 0.5% Tween 20 in PBS twice， 
sections were dipped in 2N HCl for 20 min， then， neutralized sections in borateるuffer
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(O.lM NaB407， pH 8.5)れiVice.After Tween/PBS washing， sections were dipped in 1 % 
BSNPBS for 20 min. Then， sections were incubated with 1 :20 anti-BrdU (Roche). 
Sections detected with diaminobenzidine staining were analyzed. The BrdU labeling 
index (%) was estimated by counting BrdU positive cells in 2000幽3000epithelial and 
10000・20000stromal cells in the uterus and vagina， and in 300-500 epithelial or stromal 
cells in the mammary glands. 
Results 
Gene expression in the uterus， vagina and mammαry glandαposedto E2 
Approximately 12，400 genes were analyzed in the uterus， vagina and 
mammary gland. The total normalized signals between controls and Eγexposed mice 
exhibited high correlations (R2=0.95・0.96)(Fig. 1). The total number of genes showing 
at least 2-fold expression change 6 h after a single injection ofE2 was 656 in al samples 
(Fig. 1). E2 did not alter any gene expression more than 2-fold change in the mammary 
gland in the present study (data not shown). Genes showing organ幽specificexpression 
were 155 and 351 in the uterus and vaginaラrespectively(Fig. 1). Among them， 150 
genes were regulated commonly in the uterus and vagina (Fig.l). 
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In the uterus， 228 genes were up-regulated and 77 genes were dowrトregulatedby E2 as 
compared to the controls (Fig 2). In the vagina， 446 genes were up-regulated and 35 
were dowrトregulatedby E2・Inthe uterus， 63% ofE2 up-regulated genes were 
over1apped those in the vagina. E2 dowrトregulatedcommon genes in the uterus and 
vagina were only 6 (Fig. 2). We further analyzed genes related to cel growth and 
organogenesis to find tissue岨specificgenes. E2幽responsivegenes related to development， 
cel growth and apoptosis in the uterus and vagina were listed in Table 2. 
Expression of IGF-l famめJand Kallikrein 1 genes 
Since clustering analysis revealed many E2爾regulatedgenes， we compared 
expressions of五allikrein1 (Klkl) genes and IGF-l family genes in each tissue using 
QRT幽PCR.
In the controls， expression ofKlkl mRNA was similar between both uterus and vagina， 
while those ofIGF-l and IGFBP5 were lower in the vagina than in the uterus (Fig. 3). 
In the mammary gland， unlike the uterus and vagina， expressions of al mRNAs 
examined were very low or undetectable in the ovariectomized mice with or without E2・
In the uterus and vagina， expression ofIGF-l mRNA was markedly increased by E2・
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However， expressions ofIGFBP2 and IGFBP5 mRNAs were increased by E2 inthe 
vagina (Fig. 3). Klkl mRNAs was significantly increased by E2 inthe vagina. 
BrdV incorporation in the uterus， vagina and mammary gland 24 h after E2 injection 
BrdU labeled cells were barely detected in epithelial cells of the uterus and 
mammary gland (0% and 0.05%) in the controls， ascompared to those in the vagina 
(0.24%) in the controls (Fig. 4). The BrdU labeling index in the epithelial cells ofthe 
uterus and vagina was significantly increased 24 h a長erthe E2 injection as compared 
with each control. In the mammary gland， however， BrdU-positive cells were not 
evident in the epithelium 24 h after the E2 injection.τhe index was significantly 
increased by E2 in the uterine stroma (Fig. 4). 
Discussion 
Estrogen regulates mitosis and morphological changes in female reproductive 
organs during proliferative events， such as estrous cycles， gestation and lactatIon. In 
order to understand the underlying mechanisms of estrogen functions in reproductive 
organs， detection of estrogen responsive genes in each reproductive organ is essential. 
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Effects of estrogen are different in each reproductive organ， therefore we investigated a 
global gene expression in uterus， vagina and mammary gland after a single injection of 
E2・
In the present s加dy，BrdU labeled cells were remarkably increased in the 
uterine and vaginal epithelia， and in the uterine stroma after the E2 i吋ection，but not in 
anyp訂tsof the mammary gland. Gene expression in response to estrogen is different 
among these organs. IGFぺisa key epithelial mitogen induced by estrogenic chemicals 
(Richards et al.， 1996; Sato et al.， 2002)， whereas IGFBP prevents signal pathway by 
binding to IGF-1， and inhibits phosphorylation ofInsulin receptor substrate-1 (IRS-1)， 
Phosphatidylinositol 3-kinase (PI3K)， Protein kinase B (PKB) and Forkhead 
transcription factors (FKHRL 1) (Marshman et α1.， 2003). IGFBP2 and IGFBP5 promote 
apoptosis in the prost蹴 cancercells and mammary gland cells (Marshman et al.， 2003; 
Plath-Gabler et α1.，2001; Schneider et al.， 2002; Richardsen et al.， 2003). Hence， 
proliferations of uterine and vaginal cells appeぽ tobe regulated by estrogen via IGF・1
and receptor complex， and its modulator. In the present study， estrogen increased IGF-l 
mRNA and mitosis in the uterus and vagina. However， the IG巴1modulators and 
IGFBP mRNAs were also increased in E2・exposedvagina. This may be accounted for 
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by the suppression of stromal cell proliferation caused by increase of IGFBP mRNAs in 
the stroma rather than the epithelium. 
Up-regulation ofKlk1 was reported by E2 in the uterus (Watanabe et al.， 
2002). Klk plays an important role for the release ofbradykinin企omkininogen， 
activation of growth factors and alteration of the extracellular matrix in the uterine 
epithelium (Corthom et al.， 1997). Klk isregulated hormonally (Corthom et al.， 1994， 
1997) and the gene expression was found in human ovarian， prost瓜eand breast cancer 
cells and in mouse vagina (Jacobsen et al.， 2003; Obiezu et al.， 2001; Yousef et al.， 
1999). We found the up-regulation ofKlkl gene expression in the vagina by QRT欄PCR.
Thus， Klk1 may be related to epidermal proliferation and their expressions can be used 
for markers of acute response to estrogen in the uterus and vagina. 
We found that estrogen regulated genes were markedly limited in the 
mammary gland as compared to those in the uterus and vagina 6 h after the E2 exposure. 
Global gene expression in E2・exposedmammary gland has not been reported. Only 
gene expression in human breast cancer MCF・7cells treated E2 in vitro was reported 
(Charpentier et α1.ラ2000;Frasor et al.， 2003; Gruvberger et al.， 2001). MCF-7 cells 
treated with E2 revealed the major down-regulation (70%) of gene expression including 
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transcriptionaI repressoζantiproliferative and proapoptotic genes， such as Bc1・2，Cyclin 
G2 and TGF-s family (Gruvberger et α1.，2001). Moreoverラusingthe serial analysis of 
gene expression (SAGE) method， 3 up-regulated genes were reported in MCF-7 cells 10 
h after E2 treatment in vitro (Charpentier et al.， 2000). The genes reported as E2 
dowrトregulatedgenes in MCF・7cells were not found in the mammary gland in the 
present s知dy.MCF・7cells are a single species of mammary cancer cells and show 
precise response of time-and dose岨dependentproliferation to estrogen. Normal 
mammary gland may need longer出an6 h torespond to E2 in vivo. Mammary gland has 
various types of cells， such as epithelial cel1s， myoepithelial cel1s， stromal cells and 
adipocytes. Thus， we need和rtherprecise experiment to understand estrogen responsive 
genes in the mammary gland. 
Although the mammary gland Is known to be one of the target organs of estrogen， ER-a. 
knockout(αERKO) mice showed proliferation and morphogenesis of the mammaη 
gland in adulthood (Mueller et al.， 2002). The mammaη， gland seems to be regulated by 
progesterone and prolactin rather than estrogen (Clevenger et α1.，2003; Horseman et al.， 
1999; Jacobsen et al.， 2003; Kelly et al.， 2002; Mueller et al.， 2002; Shayamalaラ1999).
Theup帽regulationofgene expression， such as IRS-l， Msx-2， CIEBPs and Stat5， by 
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progesterone was reported in human breast cancer cells (Jacobsen et al.， 2003). 
Prolactin induced expression ofIGF・2mRNA in the developing mammary gland 
(Hovey et al.， 2003). Thus， mammary gland is possibly regulated largely by 
progesterone and/or prolactin. This may account for no expression of estrogen 
responsive genes observed 6 h after the E2 exposure and absence of definite mitogenic 
response in the mammary gland of ovariectomized adult mice 24 h after the E2 
exposure. 
In conclusion， E2 regulates expression of a number of genes in the vagina and 
uterus， but not in the mammary gland. Half of E2・regulatedgenes in the uterus were in 
common with the vagina， inc1uding Kallikrein and IGF family genes. Differences in 
expression of these genes in response to E2 may be leased on the tissue specificity to 
estrogen exposure. The candidate estrogen responsive genes in the uterus and vagina 
identified by profiling provide an important foundation to understand functional 




Fig. 1. Gene expression profiles in the uterus and vagina 6 h after a single injection of 5 
μg E2/kg body weight. The Venn diagram indicates detected genes in the oil幽controls.
Scatter plots indicate gene expression levels and the correlations between oil and E2 
groups in al genes. R2 iscorrelation between oil and E2 groups. Ut， uterus; V g， vagina 
Fig. 2. Number of estrogen up-regulated genes (a) and down-regulated genes (b) in the 
uterus (Ut) and vagina (Vg).“Ut and V g" indicates genes showing commonly altered 
expression by E2 both in the uterus and vagina， while Ut and V g indicate organ specific 
genes， respectively. 
Fig. 3. Ratio ofmRNAexpressions oflGF-l familyand Kallikrein 1 in the three organs 
6 h after the E2 injection using QRT-PCR.寧，P<O.05 v.s. the control of each tissue; #，
P<O.05 v.s. the control uterus 
Fig. 4. BrdU labeling index (positive cells / counted cells， %) in epithelium and stroma 















































































































































































































































































































































































































































































































































































































































































































Table2 List of estrogen responsive genes related development， cel growth and apoptosis in the 
uterus and vagina by microarray analysis. 
Ratio 
ame Ut Vg 
Inhibitor of DNA binding 3 0.42 0.71 
Ribonuclease， RNase A family 4 0.42 1.32 
Latent transforming growth factor beta binding protein 4 0.42 1.07 
B-cellleukemia/lymphoma 2 0.43 0.59 
SRY-box containing gene 4 0.45 0.36 
Secreted企izzled-relatedprotein 2 0.45 0.89 
Sestrin 1 0.45 0.43 
Frizzled homolog 2 (Drosophila) 0.46 0.64 
Peptidoglycan recognition protein 1 1.54 0.37 
Nuclear receptor subfamily 1， group D， member 1 0.58 0.37 
Peptidoglycan recognition protein 1 1.10 0.40 
IGFl receptor 0.59 0.41 
Schlafen 2 1.02 0.46 
τhyroid hormone receptor alpha 0.72 0.49 
Ins釦叫u1辻li加nトト.幽幽批.幽 1.00 2.00 
Chromosome segregation トlike(S. cerevisiae) 1.76 2.01 
Hypoxia inducible factor 1， alpha subunit 1.57 2.01 
Phosphatidylinositol transfer protein， beta 1.24 2.02 
Keratin complex 2， basic， gene 4 1.03 2.08 
similar to DNA replication licensing factor MCM3 (PI-MCM3) 1.48 2.09 
Tumor necrosis factor superfamily， member 5-induced protein 1 0.97 2.16 
CDK2 (cyclin-dependent kinase 2)岨associatedprotein 1 1.81 2.19 
NMDA receptor幽regulatedgene 1 1.66 2.20 
Septin 2 1.48 2.20 
HtrA serine peptidase 1 1.46 2.22 
v-Kトras2Kirsten rat sarcoma viral oncogene homolog 1.95 2.26 
Prolactin receptor 1.12 2.30 
Glial cellline derived neurotrophic factor family receptorαl 1.70 2.34 
Actin-like 6A 1.96 2.36 
85 
Protein disulfide isomerase associated 3 1.92 2.38 
Apoptosis inhibitor 5 1.76 2.43 
Stratifin 1.32 2.44 
ふadenosylmethioninedecarboxylase 1 1.89 2.47 
S-adenosylmethionine decarboxylase 1 and 2 1.74 2.49 
Plasminogen 1.02 2.62 
Matrix Gla protein 0.63 2.68 
Growth arrest specific 6 1.14 2.79 
Insulin-like growth factor binding protein 5 (IGFBP5) 1.18 3.09 
Phosphatidic acid phosphatase type 2B 1.69 3.32 
Cellular retinoic acid binding protein I 1.02 3.47 
Protein arginine N-methyltransferase 1 1.86 3.49 
Aldehyde dehydrogenase family 1， subfamily Al 1.31 4.11 
Plasminogen 0.75 4.38 
Zinc finger and BTB domain containing 16 0.52 4.44 
Aldehyde dehydrogenase 18 family， member Al 2.02 1.45 
百弓..rTlinducible signaling pathway protein 1 2.03 1.38 
NMDA receptor幽regulatedgene 1 2.10 1.50 
Secreted phosphoprotein 1 2.17 1.23 
GrowthぽrestandDNA町damage明inducible45 alpha 2.18 3.08 
079528 I Neuropilin 1 2.20 1.57 
G 1 toS phase transition 1 2.21 1.66 
DnaJ (Hsp40) homolog， subfamily C， member 2 2.24 1.96 
NMDA receptor幽regulatedgene 1 2.29 2.10 
DnaJ (Hsp40) homolog， subfamily C， member 2 2.34 1.79 
Serumlglucocorticoid regulated kinase 2.38 1.02 
529583 I Mortality factor 4 like 2 2.39 3.56 
Interferon-related developmental regulator 1 2.40 2.63 
Suppressor of cytokine signaling 2 2.42 1.07 
Activating transcription factor 5 2.43 1.96 
Kallikrein 1 2.43 0.92 
Protein tyrosine phosphatase 4al 2.46 2.34 
Cyc1in-dependent kinase inhibitor lA (P21) 2.51 2.45 
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Growth arrest and DNA幽damage幽inducible45 gamma 2.53 5.03 
Receptor tyrosine kinase姐like0中hanreceptor 2 2.64 3.31 
FBJ osteosarcoma oncogene 2.66 3.22 
RAN， member RAS oncogene family 2.77 2.36 
N europilin 1 2.95 1.27 
Aldehyde dehydrogenase family 1， subfamily A2 2.99 1.90 
Gap junction membrane channel protein alpha 1 3.02 1.98 
Guanine nucleotide binding protein幽like3 (nucleolar) 3.82 2.57 
Insulin幽likegrowth factor 1 (IGF-I) 4.67 4.82 
MAD2 (mitotic arrest deficient， homolog)・4 4.75 4.57 
053232 I Nl凶 olarprotein 5 5.09 3.32 
Inhibin beta幽B I 10.29 I 7.60 
Bold means more than 2・foldalterations by E2・
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V. SummaηT and Conclusion 
1 investigated the estrogen司responsivegenes in mouse reproductive organs at perinatal 
and adult period using DNA microarray in the present study. 
First， 1 investigated gene expression change in the Mullerian duct of the 
mouse fetus exposed to diethylstilbestrol in utero (Chapterl). DES up-regulated 
appoximately 400 genes and dowrトregulated200 genes in the oviduct and uterus by 
DES in utero. However， DES-regulated genes in the vagina were half ofthose in the 
oviduct and uterus. Clustering analysis of DNA microarray revealed DES loose the 
organ-specific gene expressions in the Mullerian duct. From results of Q司PCR，DES 
repressed Wnt-4 gene in the oviduct and Wnt-7a gene in al three organs， but it induced 
expression ofWnt-5a gene in the oviduct and uterus. Hoxa・9gene was induced by DES， 
while Hoxa・10gene in the oviduct and uterus was repressed by DES. In the vagina， 
DES failed to disrupted Hoxa13 gene. The clustering analysis and Q-PCR suggested the 
downstream candidates of Hox and Wnt genes were included with ephrin B2， Eph 
receptor A4， A7， Nkd2ヲDkk2and sFRP genes. 
Second， 1 investigated global gene expression in mouse vaginae exposed to 
DES at different ages (Chapter2).DNA microarray analysis exhibited 54 DES-induced 
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genes and 9 DES-repressed genes in vaginae at PND O. Whi1eラmorethan 200 
DES-induced genes were found in vaginae at PND 5 and 20， and 350 genes at PND 70. 
Clustering analysis ofDES-induced genes in the vaginae at different ages revealed that 
genes induced by DES at PND 5 were close to the adult type rather than those at PND O. 
Genes related to keratinocyte differentiation， such as Gadd45α，p21， 14・3・3sigma， 
Spη2fand Klf4， were induced by DES. The proliferation ofvaginal epithelium at PND5 
was similar to adult one than that at PND O. The number ofDES-induced genes during 
the critical period， PND 0， was smaller than that found after the critical period. 
Third， 1 investigated comparison of estrogen明responsivegenes in the mouse 
uterus， vagina and mammaηr gland (Chapter3). In the mammary gland， gene 
expressions and mitosis were almost unchanged 6 h after the E2 exposぽe.Half of the E2 
up-regulated genes in the uterus were similar to those in the vagina. E2 up幽regulatedthe 
expression ofIG巴1genes in the uterus and vagina. In the vagina， E2 up-regulated the 
expression of IGF binding proteins (IGFBP2 and IGFBP5). These results suggest th剖
expression ofIGF-1 and morphogenesis genes is regulated by E2 in an organ-specific 
manner， which was supported by the results of BrdU labeling showing E2帽induced
mitosis in the uterus and vagina except the mammary gland. 
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Clustering analysis of global gene expressions using DNA microarray analysis 
revealed the obvious organ-specificity and age-specificity in mouse reproductive tracts. 
DES disrupted 出eorgan and age specificity of global gene expressions in mouse 
reproductive tracts during perinatal period， especially morphologic組 dkeratinocyte 
differentiation genes. Interestingly， estrogen exerts litle effect on the mammary gland as 
adults. The epigenetic mechanism of estrogenic transcription may be di鈴 rentin 
mammary gland as compared to those in mature uterus and vagina. 
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